EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Site‐specific m6A‐miR‐494‐3p, not unmethylated miR‐494‐3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis

Tamar Woudenberg, M Leontien van der Bent, Veerle Kremer, Ingeborg S E Waas, Mat J A P Daemen, Reinier A Boon, Paul H A Quax, A Yaël Nossent

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.17374 ↗

At a glance

Übersichtsarbeit in British Journal of Pharmacology, 2025. Written by Tamar Woudenberg and 7 co-authors. Institution: Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands. Major MEDLINE topics: MicroRNAs, Intracranial Arteriosclerosis, Zonula Occludens-1 Protein, Blood-Brain Barrier. Cited 6 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Netherlands Organization for Scientific Research, NovoNordisk Foundation, Novo Nordisk Foundation Center for Basic Metabolic Research.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Intracranial atherosclerosis is one of the most common causes of ischaemic stroke. However, there is a substantial knowledge gap on the development of intracranial atherosclerosis. Intracranial arteries are characterized by an upregulation of tight junctions between endothelial cells, which control endothelial permeability. We investigated the role of N6‐methyladenosine (m6A), a common RNA modification, on endothelial integrity, focusing on the pro‐atherogenic microRNA miR‐494‐3p and tight junction proteins TJP1 and PECAM1. Experimental Approach We assessed the m6A landscape, along with the expression of miR‐494‐3p, TJP1 and PECAM1 in postmortem human vertebral arteries (VA), internal carotid arteries (ICA), and middle cerebral arteries (MCA) with various stages of intimal thickening and plaque formation. The interactions between m6A‐modified miR‐494‐3p mimics, TJP1 and PECAM1, were investigated in vitro using primary human (brain) endothelial cells. Key Results Increased m6A expression was observed in the luminal lining of atherosclerosis‐affected VAs, accompanied by reduced TJP1 and PECAM1, but not VE‐cadherin, expression. Colocalization of m6A and miR‐494‐3p in the luminal lining of VA plaques was confirmed, indicating m6A methylation of miR‐494‐3p in intracranial atherosclerosis. Moreover, site‐specific m6A‐modification of miR‐494‐3p led to repression specifically of TJP1 protein expression at cell–cell junctions of brain microvascular endothelial cells, while unmodified miR‐494‐3p showed no effect. Conclusions and Implications This study highlights increasing m6A levels during intracranial atherogenesis. Increases in m6A‐miR‐494‐3p contribute to the observed decreased TJP1 expression in endothelial cell–cell junctions. This is likely to have a negative effect on endothelial integrity and may thus accelerate intracranial atherosclerosis progression.

Subjects

MeSH terms (MEDLINE)

MicroRNAsIntracranial ArteriosclerosisZonula Occludens-1 ProteinBlood-Brain BarrierTight Junction ProteinsHumansMaleEndothelial CellsCells, CulturedMiddle AgedFemalePlatelet Endothelial Cell Adhesion Molecule-1Tight JunctionsAged

Author keywords

N6‐methyladenosineTJP1intracranial atherosclerosismiR‐494‐3p

Substances

MicroRNAsZonula Occludens-1 ProteinMIRN494 microRNA, humanTJP1 protein, humanPlatelet Endothelial Cell Adhesion Molecule-1PECAM1 protein, humanTight Junction Proteins

Authors and institutions

  • Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC Location VUMc, Vrije Universiteit, Amsterdam, The Netherlands.
  • Department of Pathology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands.
  • Institute for Cardiovascular Regeneration, Centre for Molecular Medicine Goethe University, Frankfurt am Main, Germany.
  • German Center for Cardiovascular Research (DZHK), Frankfurt am Main, Germany.

Funding

  • Netherlands Organization for Scientific Research
  • NovoNordisk Foundation
  • Novo Nordisk Foundation Center for Basic Metabolic Research

Cite

APA

Woudenberg, T., van der Bent, M. L., Kremer, V., Waas, I. S. E., Daemen, M. J. A. P., Boon, R. A., Quax, P. H. A., & Nossent, A. Y. (2025). Site‐specific m6A‐miR‐494‐3p, not unmethylated miR‐494‐3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis. British Journal of Pharmacology. https://doi.org/10.1111/bph.17374

Vancouver

Woudenberg T, van der Bent ML, Kremer V, Waas ISE, Daemen MJAP, Boon RA, et al. Site‐specific m6A‐miR‐494‐3p, not unmethylated miR‐494‐3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis. British Journal of Pharmacology. 2025. doi:10.1111/bph.17374

BibTeX
@article{Woudenberg2025,
  author = {Woudenberg, Tamar and van der Bent, M Leontien and Kremer, Veerle and Waas, Ingeborg S E and Daemen, Mat J A P and Boon, Reinier A and Quax, Paul H A and Nossent, A Yaël},
  title = {Site‐specific m6A‐miR‐494‐3p, not unmethylated miR‐494‐3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.17374}
}
Start for free →